Literature DB >> 24056739

Risk factors for ICU admission and ICU survival after allogeneic hematopoietic SCT.

R Benz1, U Schanz2, M Maggiorini3, J D Seebach4, G Stussi5.   

Abstract

A considerable number of patients undergoing allogeneic hematopoietic SCT (HSCT) develop post-transplant complications requiring intensive care unit (ICU) treatment. Whereas the indications and the outcome of ICU admission are well known, the risk factors leading to ICU admission are less well understood. We performed a retrospective single-center study on 250 consecutive HSCT patients analyzing the indications, risk factors and outcome of ICU admission. Of these 250 patients, 33 (13%) were admitted to the ICU. The most common indications for admission to the ICU were pulmonary complications (11, 33%), sepsis (8, 24%), neurological disorders (6, 18%) and cardiovascular problems (2, 6%). Acute GvHD and HLA mismatch were the only significant risk factors for ICU admission in multivariate analysis. Among patients admitted to the ICU, the number of organ failures correlated negatively with survival. Twenty-one (64%) patients died during the ICU stay and the 6-month mortality was 85% (27 out of 33). SAPS II score underestimated the mortality rate. In conclusion, acute GvHD and HLA mismatch were identified as risk factors for ICU admission following allogeneic HSCT. Both, short- and long-term survival of patients admitted to the ICU remains dismal and depends on the number of organ failures.

Entities:  

Mesh:

Year:  2013        PMID: 24056739     DOI: 10.1038/bmt.2013.141

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  17 in total

1.  Outcome for cancer patients requiring mechanical ventilation.

Authors:  J S Groeger; P White; D M Nierman; J Glassman; W Shi; D Horak; K Price
Journal:  J Clin Oncol       Date:  1999-03       Impact factor: 44.544

2.  Outcome of hematopoietic stem cell transplant recipients admitted to the intensive care unit.

Authors:  Andrea K Kew; Stephen Couban; Ward Patrick; Kara Thompson; Darrell White
Journal:  Biol Blood Marrow Transplant       Date:  2006-03       Impact factor: 5.742

Review 3.  Hematopoietic stem-cell transplantation.

Authors:  Edward A Copelan
Journal:  N Engl J Med       Date:  2006-04-27       Impact factor: 91.245

Review 4.  Transfer of the hematopoietic stem cell transplant patient to the intensive care unit: does it really matter?

Authors:  N Naeem; M D Reed; R J Creger; S J Youngner; H M Lazarus
Journal:  Bone Marrow Transplant       Date:  2006-01       Impact factor: 5.483

5.  Risk factors associated with pediatric intensive care unit admission and mortality after pediatric stem cell transplant: possible role of renal involvement.

Authors:  Nabil E Hassan; Aly S Mageed; Dominic J Sanfilippo; Dianne Reischman; Ulrich A Duffner; Surender Rajasekaran
Journal:  World J Pediatr       Date:  2012-12-29       Impact factor: 2.764

6.  Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit.

Authors:  K J Price; P F Thall; S K Kish; V R Shannon; B S Andersson
Journal:  Am J Respir Crit Care Med       Date:  1998-09       Impact factor: 21.405

7.  Pulmonary complications in patients with haematological malignancies treated at a respiratory ICU.

Authors:  S Ewig; A Torres; R Riquelme; M El-Ebiary; M Rovira; E Carreras; A Raño; A Xaubet
Journal:  Eur Respir J       Date:  1998-07       Impact factor: 16.671

Review 8.  Critical care of the hematopoietic stem cell transplant recipient.

Authors:  Bekele Afessa; Elie Azoulay
Journal:  Crit Care Clin       Date:  2010-01       Impact factor: 3.598

9.  Sequential Organ Failure Assessment predicts the outcome of SCT recipients admitted to intensive care unit.

Authors:  K Gilli; M Remberger; H Hjelmqvist; O Ringden; J Mattsson
Journal:  Bone Marrow Transplant       Date:  2009-08-31       Impact factor: 5.483

10.  Admission factors associated with hospital mortality in patients with haematological malignancy admitted to UK adult, general critical care units: a secondary analysis of the ICNARC Case Mix Programme Database.

Authors:  Peter A Hampshire; Catherine A Welch; Lawrence A McCrossan; Katharine Francis; David A Harrison
Journal:  Crit Care       Date:  2009-08-25       Impact factor: 9.097

View more
  15 in total

1.  A reappraisal of ICU and long-term outcome of allogeneic hematopoietic stem cell transplantation patients and reassessment of prognosis factors: results of a 5-year cohort study (2009-2013).

Authors:  L Platon; L Amigues; P Ceballos; N Fegueux; D Daubin; N Besnard; R Larcher; L Landreau; C Agostini; S Machado; O Jonquet; K Klouche
Journal:  Bone Marrow Transplant       Date:  2015-11-16       Impact factor: 5.483

2.  Acute kidney injury in critically ill allo-HSCT recipients.

Authors:  E Canet; E Lengline; L Zafrani; M-N Peraldi; G Socié; E Azoulay
Journal:  Bone Marrow Transplant       Date:  2014-05-12       Impact factor: 5.483

3.  Clinical impact of pre-transplant diastolic function on outcome after allogeneic hematopoietic SCT.

Authors:  N Shingai; K Kakihana; G Oshikawa; T Kobayashi; N Doki; H Sakamaki; K Ohashi
Journal:  Bone Marrow Transplant       Date:  2014-06-16       Impact factor: 5.483

4.  Prognostic factors in critically ill patients with hematological malignancy admitted to the general intensive care unit: a single-center experience in Japan.

Authors:  Hiromasa Irie; Takanao Otake; Keiko Kawai; Masaaki Hino; Ayano Namazu; Yasutaka Shinjo; Shigeki Yamashita
Journal:  J Anesth       Date:  2017-08-01       Impact factor: 2.078

Review 5.  Intensive care outcomes in adult hematopoietic stem cell transplantation patients.

Authors:  Ulas D Bayraktar; Joseph L Nates
Journal:  World J Clin Oncol       Date:  2016-02-10

6.  Changes in intensive care for allogeneic hematopoietic stem cell transplant recipients.

Authors:  E Lengliné; S Chevret; A-S Moreau; F Pène; F Blot; J-H Bourhis; A Buzyn; B Schlemmer; G Socié; E Azoulay
Journal:  Bone Marrow Transplant       Date:  2015-03-23       Impact factor: 5.483

7.  Improved short- and long-term outcome of allogeneic stem cell recipients admitted to the intensive care unit: a retrospective longitudinal analysis of 942 patients.

Authors:  Catherina Lueck; Michael Stadler; Christian Koenecke; Marius M Hoeper; Elke Dammann; Andrea Schneider; Jan T Kielstein; Arnold Ganser; Matthias Eder; Gernot Beutel
Journal:  Intensive Care Med       Date:  2018-08-23       Impact factor: 17.440

8.  Short- and long-term outcomes of adult allogeneic hematopoietic stem cell transplant patients admitted to the intensive care unit in the peritransplant period.

Authors:  Sebastian Mayer; Stephen M Pastores; Elyn Riedel; Molly Maloy; Ann A Jakubowski
Journal:  Leuk Lymphoma       Date:  2016-06-27

Review 9.  Critically ill allogeneic hematopoietic stem cell transplantation patients in the intensive care unit: reappraisal of actual prognosis.

Authors:  C Saillard; D Blaise; D Mokart
Journal:  Bone Marrow Transplant       Date:  2016-04-04       Impact factor: 5.483

10.  The role of a critical care outreach service in the management of patients with haematological malignancy.

Authors:  Leila Taheri; Rathai Anandanadesan; Hugues de Lavallade; Eirini Pagkalidou; Antonio Pagliuca; Ghulam Mufti; Georg Auzinger; Victoria Metaxa
Journal:  J Intensive Care Soc       Date:  2019-06-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.